These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 8803908)
21. High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease. Coll J; Anglada J; Tomas S; Reth P; Goday A; Millan M; Pujol-Borrell R; Corominas J J Rheumatol; 1997 Sep; 24(9):1719-24. PubMed ID: 9292794 [TBL] [Abstract][Full Text] [Related]
22. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study. Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226 [TBL] [Abstract][Full Text] [Related]
23. Recognition and management of Sjögren's syndrome: strategies for the advanced practice nurse. Vale DL Nurs Clin North Am; 2000 Mar; 35(1):267-78. PubMed ID: 10673580 [TBL] [Abstract][Full Text] [Related]
24. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects. Gannot G; Lancaster HE; Fox PC J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331 [TBL] [Abstract][Full Text] [Related]
25. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up. Theander E; Andersson SI; Manthorpe R; Jacobsson LT J Rheumatol; 2005 Aug; 32(8):1495-502. PubMed ID: 16078325 [TBL] [Abstract][Full Text] [Related]
27. Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. Font J; Ramos-Casals M; de la Red G; Pou A; Casanova A; García-Carrasco M; Cervera R; Molina JA; Valls J; Bové A; Ingelmo M; Graus F J Rheumatol; 2003 Jul; 30(7):1552-7. PubMed ID: 12858457 [TBL] [Abstract][Full Text] [Related]
28. Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study. Cankaya H; Alpöz E; Karabulut G; Güneri P; Boyacioglu H; Kabasakal Y Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):62-7. PubMed ID: 20610299 [TBL] [Abstract][Full Text] [Related]
29. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659 [TBL] [Abstract][Full Text] [Related]
30. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome. Lee M; Rutka JA; Slomovic AR; McComb J; Bailey DJ; Bookman AA J Rheumatol; 1998 Feb; 25(2):247-53. PubMed ID: 9489815 [TBL] [Abstract][Full Text] [Related]
31. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome]. Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028 [TBL] [Abstract][Full Text] [Related]
32. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900 [TBL] [Abstract][Full Text] [Related]
33. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213 [TBL] [Abstract][Full Text] [Related]
34. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study. Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of clinical symptoms and laboratory data as diagnostic criteria for Sjögren's syndrome]. Skopouli FN; Papaioannou T; Kitsios G; Drosos AA; Psilas C Ter Arkh; 1988; 60(4):60-3. PubMed ID: 2455941 [TBL] [Abstract][Full Text] [Related]
37. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome. Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918 [TBL] [Abstract][Full Text] [Related]
38. [Sjögren's syndrome in the elderly]. Gentric-Tilly A Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study. Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277 [TBL] [Abstract][Full Text] [Related]
40. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS; Severns ML Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]